CXCL12 and diabetes mellitus: A study reported that after 4-week treatment, patients with DM treated with sitagliptin exhibited significant increases in the number of circulating endothelial progenitor cells (EPCs) and level of SDF-1α compared with controls (Fadini et al., 2010).